Search

Author/Creator Ohkubo, Shuichi

1. Acquired resistance to trastuzumab/pertuzumab or to T‐DM1 in vivo can be overcome by HER2 kinase inhibition with TAS0728. Issue 6 (30th April 2020)

Authors:
Irie, Hiroki; Kawabata, Rumi; Fujioka, Yayoi; Nakagawa, Fumio; Itadani, Hiraku; Nagase, Hideki; Ito, Kimihiro; Uchida, Junji; Ohkubo, Shuichi; Matsuo, Kenichi
Journal:
Cancer science
Issue:
Volume 111:Issue 6(2020)
Page Start:
2123
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Activity of TAS4464, a novel NEDD8 activating enzyme E1 inhibitor, against multiple myeloma via inactivation of nuclear factor κB pathways. Issue 12 (23rd October 2019)

Authors:
Muraoka, Hiromi; Yoshimura, Chihoko; Kawabata, Rumi; Tsuji, Shingo; Hashimoto, Akihiro; Ochiiwa, Hiroaki; Nakagawa, Fumio; Fujioka, Yayoi; Matsuo, Kenichi; Ohkubo, Shuichi
Journal:
Cancer science
Issue:
Volume 110:Issue 12(2019)
Page Start:
3802
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors. Issue 12 (21st February 2023)

Authors:
Teranishi, Ryugo; Takahashi, Tsuyoshi; Obata, Yuuki; Nishida, Toshirou; Ohkubo, Shuichi; Kazuno, Hiromi; Saito, Yurina; Serada, Satoshi; Fujimoto, Minoru; Kurokawa, Yukinori; Saito, Takuro; Yamamoto, Kazuyoshi; Yamashita, Kotaro; Tanaka, Koji; Makino, Tomoki; Nakajima, Kiyokazu; Hirota, Seiichi; ...
Journal:
International journal of cancer
Issue:
Volume 152:Issue 12(2023)
Page Start:
2580
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. DUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA‐repair‐defective human cancer cells. Issue 1 (20th November 2020)

Authors:
Yokogawa, Tatsushi; Yano, Wakako; Tsukioka, Sayaka; Osada, Akiko; Wakasa, Takeshi; Ueno, Hiroyuki; Hoshino, Takuya; Yamamura, Keisuke; Fujioka, Akio; Fukuoka, Masayoshi; Ohkubo, Shuichi; Matsuo, Kenichi
Journal:
Cancer science
Issue:
Volume 112:Issue 1(2021)
Page Start:
422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Efficacy and safety of TAS-116, an oral inhibitor of heat shock protein 90, in patients with metastatic or unresectable gastrointestinal stromal tumour refractory to imatinib, sunitinib and regorafenib: a phase II, single-arm trial. (November 2019)

Authors:
Doi, Toshihiko; Kurokawa, Yukinori; Sawaki, Akira; Komatsu, Yoshito; Ozaka, Masato; Takahashi, Tsuyoshi; Naito, Yoichi; Ohkubo, Shuichi; Nishida, Toshirou
Journal:
European journal of cancer
Issue:
Volume 121(2019)
Page Start:
29
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pharmacologic dissection of the overlapping impact of heat shock protein family members on platelet function. (30th March 2020)

Authors:
Jackson, Joseph W.; Rivera‐Marquez, Genesis M.; Beebe, Kristin; Tran, Andy D.; Trepel, Jane B.; Gestwicki, Jason E.; Blagg, Brian S. J.; Ohkubo, Shuichi; Neckers, Leonard M.
Journal:
Journal of thrombosis and haemostasis
Issue:
Volume 18:Number 5(2020)
Page Start:
1197
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗